Patient Leaflet Updated 07-Nov-2023 | GlaxoSmithKline UK
Adartrel 0.25, 0.5, and 2.0 mg film-coated Tablets
ADARTREL (logo) 0.25 mg, 0.5 mg, 2 mg film-coated tablets
ropinirole (as hydrochloride)
ADARTREL (logo) film-coated tablets
ropinirole
1. What Adartrel is and what it is used for
2. What you need to know before you take Adartrel
3. How to take Adartrel
4. Possible side effects
5. How to store Adartrel
6. Contents of the pack and other information
The active ingredient in Adartrel is ropinirole, which belongs to a group of medicines called dopamine agonists. Dopamine agonists act in a similar way to a natural substance called dopamine, in the brain.
Adartrel is used to treat the symptoms of moderate to severe restless legs syndrome.
Restless legs syndrome (RLS) is also called Ekbom syndrome. People with restless legs syndrome have an irresistible urge to move their legs, and sometimes their arms and other parts of their bodies. Usually, they have unpleasant sensations in their limbs - sometimes described as ‘crawling’ or ‘bubbling’ - which can begin as soon as they sit or lie down, and are relieved only by movement. So they often have problems with sitting still and especially with sleeping.
Adartrel relieves the unpleasant sensations, and so reduces the urge to move the legs and other limbs.
Talk to your doctor or pharmacist before taking Adartrel:
Tell your doctor if you experience symptoms such as depression, apathy, anxiety, fatigue, sweating or pain after stopping or reducing your Adartrel treatment (called dopamine agonist withdrawal syndrome or DAWS). If the problems persist more than a few weeks, your doctor may need to adjust your dose.
Tell your doctor if you or your family/carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These are called impulse control disorders and can include behaviours such as addictive gambling, excessive eating or spending, an abnormally high sex drive or an increase in sexual thoughts or feelings. Your doctor may need to adjust or stop your dose.
Tell your doctor if you or your family/carer notices that you are developing episodes of overactivity, elation or irritability (symptoms of mania). These may occur with or without the symptoms of impulse control disorders (see above). Your doctor may need to adjust or stop your dose.
Please tell your doctor or pharmacist if you are taking, or have recently taken, any other medicines, including any herbal medicines or other medicines you obtained without a prescription. Remember to tell your doctor or pharmacist if you begin taking a new medicine while you are taking Adartrel.
Some medicines can affect the way Adartrel works or make it more likely that you will have side effects. Adartrel can also affect how some other medicines work.
These include:
You will require additional blood tests if you are taking these medicines with Adartrel:
Adartrel is not recommended if you are pregnant, unless your doctor advises that the benefit to you of taking it is greater than the risk to your unborn baby. Adartrel is not recommended if you are breast-feeding, as it can affect your milk production.
Tell your doctor if you or your family notices that you are developing any unusual behaviours (such as an unusual urge to gamble or increased sexual urges and/or behaviours) while you are taking Adartrel. Your doctor may need to adjust or stop your dose.
If you take Adartrel with food, you may be less likely to feel sick (nauseous) or be sick (vomit). So it may be best to take it with food if you can.
Some people taking Adartrel find that their RLS symptoms get worse - for example, symptoms may start earlier than usual or be more intense, or affect other previously unaffected limbs, such as the arms or return in the early morning.
Adartrel tablets contain a small amount of sugar called lactose monohydrate
If you have an intolerance to lactose monohydrate or any other sugars, ask your doctor for advice before you take Adartrel.
Adartrel tablets contain less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium-free”.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Do not give Adartrel to children. Adartrel is not normally prescribed for people under 18.
It may take a while to find out what is the best dose of Adartrel for you.
The usual starting dose is 0.25 mg once a day. After two days, your doctor will probably increase your dose to 0.5 mg daily for the rest of the week. Then your doctor may gradually increase your dose over the next three weeks, up to a daily dose of 2 mg.
If a 2 mg daily dose does not improve your RLS symptoms enough, your doctor may gradually increase your dose some more, up to a maximum of 4 mg daily. After you have been taking Adartrel for three months, your doctor may adjust your dose or advise you to stop taking it.
If you feel that the effects of Adartrel are too strong or too weak, talk to your doctor or your pharmacist. Do not take more tablets than your doctor has recommended.
Carry on taking Adartrel as your doctor advises, even if you do not feel better. Adartrel may take a few weeks to work for you.
Take your Adartrel tablet(s) once a day.
Swallow the tablet(s) with a glass of water.
You can take Adartrel with or without food. If you take it with food, you may be less likely to feel sick (nauseous).
Adartrel is usually taken just before bedtime, but you can take it up to 3 hours before you go to bed.
Contact a doctor or pharmacist immediately. If possible, show them the Adartrel pack.
Someone who has taken an overdose of Adartrel may have any of these symptoms: feeling sick (nausea), being sick (vomiting), dizziness (a spinning sensation), feeling drowsy, mental or physical tiredness, fainting, hallucinations.
Do not take extra tablets or a double dose to make up for a missed dose. Just take your next dose at the usual time.
If you have missed your dose for more than a few days, ask your doctor for advice on how to start taking it again.
Do not stop taking Adartrel without advice.
Take Adartrel for as long as your doctor recommends. Do not stop unless your doctor advises you to.
If you suddenly stop taking Adartrel, your Restless leg syndrome symptoms may quickly get much worse.
A sudden stop could cause you to develop a medical condition called neuroleptic malignant syndrome which may represent a major health risk. The symptoms include: akinesia (loss of muscle movement), rigid muscles, fever, unstable blood pressure, tachycardia (increased heart rate), confusion, depressed level of consciousness (e.g. coma).
If you need to stop taking Adartrel, your doctor will reduce your dose gradually.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone gets them.
Side effects with this medicine are more likely to happen when you first start taking it, or when your dose has just been increased. They are usually mild, and may become less troublesome after you have taken the dose for a while.
If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet.
Very common side effects
These may affect more than 1 in 10 people taking Adartrel:
Common side effects
These may affect up to 1 in 10 people taking Adartrel:
Uncommon side effects
These may affect up to 1 in 100 people taking Adartrel:
Very rare side effects
A very small number of people taking Adartrel (up to 1 in 10,000) have had:
Some patients may have the following side effects (frequency not known: cannot be estimated from the available data)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
Do not store Adartrel above 25 °C. Store it in its original package in order to protect from light.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is ropinirole (as hydrochloride).
Each tablet contains 0.25, 0.5 or 2 mg of ropinirole (as hydrochloride).
The other ingredients are:
Adartrel 0.25 mg is provided as white, pentagonal-shaped film-coated tablets, marked ‘SB’ on one side and ‘4890’ on the other. Each pack contains 12 tablets.
Adartrel 0.5 mg is provided as yellow, pentagonal-shaped film-coated tablets marked ‘SB’ on one side and ‘4891’ on the other. Each pack contains 28 tablets.
Adartrel 2 mg is provided as pink, pentagonal-shaped film-coated tablets marked ‘SB’ on one side and ‘4893’ on the other. Each pack contains 28 tablets.
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
France, Germany, Poland, Portugal, Slovakia, Spain, Sweden and the United Kingdom (Northern Ireland): Adartrel
Other formats
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:
0800 198 5000 (UK Only)
Please be ready to give the following information:
Product name Adartrel 0.25 mg
Adartrel 0.5 mg
Adartrel 2 mg
Reference number 19494/0033
This is a service provided by the Royal National Institute of Blind People.
This leaflet was last revised in May2023.
Trade marks are owned by or licensed to the GSK group of companies
© 2023 GSK group of companies or its licensor’
980 Great West Road, Brentford, Middlesex, TW8 9GS, UK